95954 ā
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds with one or more PāC bonds; Phosphonic acids RP(=O)(OH); Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups Aromatic acids (P-C aromatic linkage)
COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
#2METHODS AND COMPOSITIONS FOR DECROSSLINKING BIOLOGICAL SAMPLES
#3COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
#4NEAR-INFRARED ABSORBING COMPOSITION, NEAR-INFRARED ABSORBING FILM, NEARINFRARED ABSORBING FILTER AND IMAGE SENSOR FOR SOLID-STATE IMAGING ELEMENTS
#5ELECTRONIC SWITCHING DEVICE
#6Modified graphene, method of producing modified graphene, modified graphene-resin composite, modified graphene sheet, and modified graphene dispersion
#7Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#8Aromatic compounds and use thereof for formation of molecular layers and fabrication of switching elements for memristive devices
#9Light-absorbing composition and optical filter
#10QUINAZOLINE AND INDOLE COMPOUNDS TO TREAT MEDICAL DISORDERS
#11Modified graphene, method of producing modified graphene, modified graphene-resin composite, modified graphene sheet, and modified graphene dispersion
#12Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#13STAT3 dimerization inhibitors
#14Quinazoline and indole compounds to treat medical disorders
#15Light-absorbing composition and optical filter
#16BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS
#17Quinazoline and indole compounds to treat medical disorders
#18Infrared-absorbing composition, infrared-cut filter, and imaging optical system
#19STAT3 dimerization inhibitors
#20Bicyclic aryl sphingosine 1-phosphate analogs
#21Bicyclic aryl sphingosine 1-phosphate analogs
#22Flame-retardant expandable polymers
#23Image recording paper medium and image recording method
#24Bicyclic aryl sphingosine 1-phosphate analogs
#25Production process for self-dispersible pigment, self-dispersible pigment, ink, ink cartridge and ink jet recording method
#26STAT3 dimerization inhibitors
#27Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder
#28Activators of glucokinase
#29Fused aromatic PTP-1B inhibitors
#30Fused pyrimidine derivatives for inhibition of tyrosine kinase activity
#31Method for producing phenylphosphonic acid metal salt composition, and crystal nucleating agent therefrom
#32Bicyclic aryl sphingosine 1-phosphate analogs
#33CaSR agonists
#34Non-halogen flame retardant polymers
#35PHOSPHONIC ACID COMPOUNDS AS SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATORS
#36ALKENE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
#37Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
#38NOVEL AROMATIC THIO COMPOUNDS AS RECEPTOR MODULATORS
#39ALLENE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
#40Beta-hydroxy-gamma-aminophosphonates for treating immune disorders
#41Hypophosphorous acid derivatives having antihyperalgic activity and biological applications thereof
#42Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#43NOVEL OXIME DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
#44Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
#45Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
#46Fused aromatic PTP-1B inhibitors
#47Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#48Proton conducting materials
#49Compounds as receptor modulators with therapeutic utility
#50Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
#51Glutamate derivatives or salts thereof
#52THERAPEUTIC COMPOUNDS
#53AMMONIUM SALTS OF 9,10-DIHYDRO-10-HYDROXY-9-OXA-10-PHOSPHA-PHENANTHRENE-10-ONE
#54Proton conducting materials
#55Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
#56Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#57METHOD FOR PRODUCING STRONGLY ACIDIC ZIRCONIUM PARTICLES, PROTON CONDUCTING MATERIAL, METHOD FOR PRODUCING PROTON CONDUCTING MEMBRANE, PROTON CONDUCTING MEMBRANE, ELECTRODE FOR FUEL CELL, MEMBRANE ELECTRODE ASSEMBLY, FUEL CELL
#58Bicyclic aryl sphingosine 1-phosphate analogs
#59Fused aromatic PTP-1B inhibitors
#60Oxime derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#61Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
#62Methods of making layered mixed-metal phosphonates for high dielectric strength polymer nanocomposites
#63Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same
#64Method for producing phosphonic acid metal salt fine particles
#65Proton conducting materials
#66Activators of glucokinase
#67Melamine phenylphosphonate flame retardant compositions
#68CaSR agonists
#69PRODUCTION PROCESS OF PHOSPHONIC ACID METAL SALT AND THERMOPLASTIC RESIN COMPOSITION CONTAINING PHOSPHONIC ACID METAL SALT
#70Production of organic solvent solutions of rare-earth organophosphates
#71Layered mixed-metal phosphonates for high dielectric strength polymer nanocomposites
#72Reactive Extraction of Free Organic Acids from the Ammonium Salts Thereof
#73Processes for the preparation of calixarene derivatives
#74Fused aromatic PTP-1B inhibitors
#75ORGANOMETAL BENZENEPHOSPHONATE COUPLING AGENTS
#76Therapeutic compounds
#77PROTON CONDUCTING MATERIALS
#78Production Of Monomer, Oligomer And Polymer Phosphonic Acid Esters And Phosphonic And Sulphonic Acids By A Nucleophile Aromatic Substitution
#79Therapeutic compounds
#80Therapeutic amides
#81Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia
#82Therapeutic compounds
#83THERAPEUTIC COMPOUNDS
#84Therapeutic compounds
#85Therapeutic cyclopentane derivatives
#86Substituted picolinamides as MAO-B inhibitors useful for treating obesity
#87METHODS FOR THE PREPARATION OF PHOSPHONIC ACID DERIVATIVES
#88Use of phosphonazo III for the measurement of calcium, magnesium and sodium in analytical samples
#89Diarylurea derivatives and their use as chloride channel blockers
#90CaSR antagonist
#91Charcoal stabilization of phenyl phosphates
#92Metal phosphonates and related nanocomposites
#93Benzenedicarboxylic acid derivatives
#94Innovative method for the preparation of proton conducting nanopolymeric membranes for use in fuel cells or in catalytic membrane reactors
#95Charcoal stabilization of phenyl phosphates